KEAP1 and cancer: NFE2L2 subsequently translocates into the nucleus and transactivates a series of cytoprotective genes, including NQO1, GCLC and GST. Notably, somatic mutations that stabilise NFE2L2, thus conferring protection against oxidative stress, have been identified in KEAP1 in human cancers [32].